Not all people with CLL call for therapy. Even with all recent innovations, the iwCLL still recommends watchful observation for clients with asymptomatic illness.86 This recommendation is predicated on at least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both of those trials https://demosthenesj433vmb0.blogproducer.com/profile